Literature DB >> 33232190

Low rate of COVID-19 seroconversion in health-care workers at a Department of Infectious Diseases in Sweden during the later phase of the first wave; a prospective longitudinal seroepidemiological study.

Mulki Rashid-Abdi1, Anders Krifors1,2,3, Andreas Sälléber4, Jenny Eriksson4, Emeli Månsson1,3.   

Abstract

Background: Health-care workers are at risk of contracting and transmitting SARS-CoV-2. The aim of this study was to investigate the prevalence of SARS-CoV-2 IgG antibodies and the rate of seroconversion in an environment with high exposure to SARS-CoV-2.
Methods: 131 health-care workers at the Department of Infectious Diseases in Västerås, Sweden, were included in the study. Abbott's SARS-COV-2 IgG immunoassay was used with a signal cut-off ratio of ≥1.4. Every third week from the beginning of May, blood samples were drawn, and the participants completed a questionnaire regarding symptoms consistent with COVID-19 and the result of any SARS-CoV-2 PCR performed since the last sampling occasion. Participants with IgG antibodies against SARS-CoV-2 were re-sampled only on the sixth and last occasion.
Results: At the start of the study, 18 (15%) participants had SARS-CoV-2 IgG antibodies. At the end, 25 (19%) of 131 participants were seropositive. One case of asymptomatic infection was detected, and two cases with PCR-confirmed COVID-19 did not develop IgG antibodies.
Conclusion: The low rate of seroconversion during the study suggests that it is possible to prevent transmission of SARS-COV-2 in a high-exposure environment. Compliance with adequate infection control guidelines is the likely explanation of our findings.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; health-care workers; seroprevalence

Year:  2020        PMID: 33232190     DOI: 10.1080/23744235.2020.1849787

Source DB:  PubMed          Journal:  Infect Dis (Lond)        ISSN: 2374-4243


  6 in total

1.  Update Alert 7: Epidemiology of and Risk Factors for Coronavirus Infection in Health Care Workers.

Authors:  Roger Chou; Tracy Dana; Shelley Selph; Annette M Totten; David I Buckley; Rongwei Fu
Journal:  Ann Intern Med       Date:  2021-02-09       Impact factor: 25.391

2.  Healthcare institutions' recommendation regarding the use of FFP-2 masks and SARS-CoV-2 seropositivity among healthcare workers: a multicenter longitudinal cohort study.

Authors:  Cédric Hirzel; Alexia Cusini; Katarzyna Szajek; Felix Fleisch; Sandra Hutter; Martin Risch; Theresa Bechmann; Valerie A Luyckx; Sabine Güsewell; Amico Study Group
Journal:  Antimicrob Resist Infect Control       Date:  2022-01-10       Impact factor: 4.887

3.  Longitudinal Follow Up of Immune Responses to SARS-CoV-2 in Health Care Workers in Sweden With Several Different Commercial IgG-Assays, Measurement of Neutralizing Antibodies and CD4+ T-Cell Responses.

Authors:  Emelie Marklund; Susannah Leach; Kristina Nyström; Anna Lundgren; Jan-Åke Liljeqvist; Staffan Nilsson; Aylin Yilmaz; Lars-Magnus Andersson; Mats Bemark; Magnus Gisslén
Journal:  Front Immunol       Date:  2021-11-02       Impact factor: 7.561

4.  Global Percentage of Asymptomatic SARS-CoV-2 Infections Among the Tested Population and Individuals With Confirmed COVID-19 Diagnosis: A Systematic Review and Meta-analysis.

Authors:  Qiuyue Ma; Jue Liu; Qiao Liu; Liangyu Kang; Runqing Liu; Wenzhan Jing; Yu Wu; Min Liu
Journal:  JAMA Netw Open       Date:  2021-12-01

5.  Assessment of Diagnostic Specificity of Anti-SARS-CoV-2 Antibody Tests and Their Application for Monitoring of Seroconversion and Stability of Antiviral Antibody Response in Healthcare Workers in Moscow.

Authors:  Vera S Kichatova; Fedor A Asadi Mobarkhan; Ilya A Potemkin; Sergey P Zlobin; Oksana M Perfilieva; Vladimir T Valuev-Elliston; Alexander V Ivanov; Sergey A Solonin; Mikhail A Godkov; Maria G Belikova; Mikhail I Mikhailov; Karen K Kyuregyan
Journal:  Microorganisms       Date:  2022-02-12

6.  Sero-Prevalence and Sero-Incidence of Antibodies to SARS-CoV-2 in Health Care Workers in Israel, Prior to Mass COVID-19 Vaccination.

Authors:  Khitam Muhsen; Mitchell J Schwaber; Jihad Bishara; Eias Kassem; Alaa Atamna; Wasef Na'amnih; Sophy Goren; Anya Bialik; Jameel Mohsen; Yona Zaide; Nimrod Hazan; Ortal Ariel-Cohen; Regev Cohen; Pnina Shitrit; Dror Marchaim; Shmuel Benenson; Debby Ben-David; Bina Rubinovitch; Tamar Gotessman; Amir Nutman; Yonit Wiener-Well; Yasmin Maor; Yehuda Carmeli; Dani Cohen
Journal:  Front Med (Lausanne)       Date:  2021-06-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.